Offering prospective SNR calculation derived from prescribed slices, the SNR Calculator reportedly facilitates a higher degree of accuracy with quantitative SNR values beyond that of calculators from device manufacturers.

The Voluson Performance 18 and 16 ultrasound devices reportedly combine enhanced imaging capabilities with AI-enabled efficiencies.

In light of emerging research suggesting an increased incidence of breast cancer among women under the age of 40, breast radiologists discuss what they’re seeing in practice and emphasize increased vigilance to facilitate early detection.

What other intangibles could a radiologist bring to the table in cases of declining or lost vision?

Catch up on the top radiology content of the past week.

Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cancer as multiparametric MRI, according to research involving 22 centers in 12 countries.

The AI-powered Tempus Pixel software update provides T1 and T2 inline maps to augment cardiac MRI assessment.

The latest edition of the Hermia software reportedly facilitates standard evaluation of amyloid PET quantification across a variety of tracers and protocols.

For HER2-positive breast cancer patients with radiologic complete response on breast MRI after neoadjuvant chemotherapy (NAC), the absence of calcifications was associated with over a 13 percent higher positive predictive value (PPV) for pathologic complete response (pCR).

Researchers also found that low-dose chest CT detection of emphysema was associated with a 29 percent higher risk of all-cause mortality up to 25 years later, according to a study involving over 9,000 individuals with a history of smoking.

Circumferential aneurysm wall enhancement on MRI was associated with a 3.8-fold higher risk of intracranial aneurysm instability within a four-year period, according to a study involving over 1,350 patients.

In a recent interview, Camille Simard, M.D., MSc, discussed findings from a new study assessing elevated risks of spontaneous pregnancy loss and congenital anomalies associated with CT exposure in the month prior to conception.

New research shows that over 94 percent of patients who had a PSA level of < 0.2 ng/mL and low-volume disease assessment six months after initiation of apalutamide and androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer had radiographic progression-free survival at 24 months.

Encouraging an environment of civility and trust on the social media platforms in radiology may help open more doors for the profession.

Catch up on the top radiology content of the past week.